An Effective Model for Predicting Phage-Host Interactions Via Graph Embedding Representation Learning With Multi-Head

Insights

Bacteriophage therapy offers a promising alternative to antibiotics for treating bacterial infections. GERMAN-PHI accurately predicts phage-host interactions, overcoming limitations of existing models for effective phage therapy development.

Area of Science:

  • Microbiology
  • Bioinformatics
  • Computational Biology

Background:

  • Antibiotic resistance and dysbiosis necessitate alternative treatments for bacterial infections.
  • Phage therapy, using bacteriophages to target specific bacteria, is a viable alternative.
  • Accurate prediction of phage-host interactions is crucial for effective phage therapy.

Purpose of the Study:

  • To develop an effective model for predicting phage-host interactions.
  • To address the challenges of sparsity and unconnectedness in phage-host networks.
  • To improve the accuracy of phage-host interaction prediction for therapeutic applications.

Main Methods:

  • Proposed GERMAN-PHI model utilizing Graph Embedding Representation learning with Multi-head Attention.
  • Employed a Graph Attention Network (GAT) with talking-heads for representation learning.
  • Utilized neural induction matrix completion to reconstruct the phage-host association matrix.

Main Results:

  • GERMAN-PHI demonstrated superior performance compared to state-of-the-art methods.
  • The model effectively addresses sparsity and unconnectedness in phage-host networks.
  • Case studies showed high accuracy in predicting validated phages for human pathogens.

Conclusions:

  • GERMAN-PHI is an effective model for predicting phage-host interactions.
  • The model's attention mechanism enhances representation learning from sparse networks.
  • GERMAN-PHI facilitates the discovery of novel phage-host associations for therapeutic development.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.3K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.7K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
72
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101